Business NewsPR NewsWire • Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012

Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012

Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012

GREENWOOD VILLAGE, Colo., Nov. 28, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (AMPE), a biopharmaceutical company developing repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual...

View More : http://www.prnewswire.com/news-releases/ampio-pharmaceuticals-inc-ampe-announces-appointment-of-josh-disbrow-as-chief-op...
Releted News by prnewswire
China Nepstar Chain Drugstore Reports Third Quarter 2012 Financial Results
Publicis Groupe : Conseil du 27 novembre 2012
Publicis Groupe: Supervisory Board of November, 27th 2012
Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012
HNA Tourism Unveils First Luxury Cruise Ship in Mainland China
High Degree of Disease Prevalence Sustains Diabetes Diagnostics Market in Europe, Finds Frost & Sullivan